“Microbial Metabolism of Rofecoxib, A Selective COX-2 Inhibitor”. International Journal of Biotechnology for Wellness Industries 1, no. 4 (January 6, 2013): 235–240. Accessed January 1, 2026. https://neolifescience.com/index.php/ijbwi/article/view/463.